Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Professor John Bell talks about the beginning of the Weatherall Institute of Molecular Medicine and the many researchers who moved from Stanford to Oxford to benefit from its unique environment.

Professor Bell tells us about these early days of PCR, the biology of T cells, research focussing on the structure or the function of cell surface receptors, and the huge drive that genetics has brought to the general field of immunology.

Professor John Bell

john-headshotJohn Bell is the Regius Professor of Medicine at the University of Oxford, and former President of the Academy of Medical Sciences. After undertaking his medical training in Oxford as a Rhodes Scholar and later at Stanford University, he returned to the UK in 1987. In 1992, he became the Nuffield Professor of Clinical Medicine, and has since led the expansion of biomedical research activities within the Department, particularly in the field of genetics and genomics. His research programmes have contributed to a clearer understanding of type 1 diabetes, rheumatoid arthritis, and also of the molecular interactions associated with immune activation.

Translational Medicine

From Bench to Bedside

Ultimately, medical research must translate into improved treatments for patients. At the Nuffield Department of Medicine, our researchers collaborate to develop better health care, improved quality of life, and enhanced preventative measures for all patients. Our findings in the laboratory are translated into changes in clinical practice, from bench to bedside.